

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of skin barrier (GO:0061436) | 7.95460129 |
| 2 | regulation of water loss via skin (GO:0033561) | 7.32454489 |
| 3 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.40114596 |
| 4 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.74992894 |
| 5 | apoptotic cell clearance (GO:0043277) | 4.68558909 |
| 6 | detection of other organism (GO:0098543) | 4.65205305 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.63509534 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.63509534 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.63509534 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.63509534 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.63509534 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.63509534 |
| 13 | multicellular organismal water homeostasis (GO:0050891) | 4.60094896 |
| 14 | detection of bacterium (GO:0016045) | 4.55989563 |
| 15 | estrogen biosynthetic process (GO:0006703) | 4.55913051 |
| 16 | lipoxygenase pathway (GO:0019372) | 4.55607899 |
| 17 | glycolipid catabolic process (GO:0019377) | 4.47523581 |
| 18 | amino sugar catabolic process (GO:0046348) | 4.43666073 |
| 19 | positive regulation of cholesterol efflux (GO:0010875) | 4.27898311 |
| 20 | microglial cell activation (GO:0001774) | 4.19614758 |
| 21 | ceramide catabolic process (GO:0046514) | 4.09602779 |
| 22 | keratinocyte differentiation (GO:0030216) | 3.97807318 |
| 23 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.96460803 |
| 24 | water homeostasis (GO:0030104) | 3.94803477 |
| 25 | mannose metabolic process (GO:0006013) | 3.90504371 |
| 26 | N-acetylneuraminate metabolic process (GO:0006054) | 3.88500890 |
| 27 | gonadal mesoderm development (GO:0007506) | 3.85267883 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.80676446 |
| 29 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.76316112 |
| 30 | adenosine receptor signaling pathway (GO:0001973) | 3.75803502 |
| 31 | androgen biosynthetic process (GO:0006702) | 3.75718337 |
| 32 | positive regulation of leukocyte degranulation (GO:0043302) | 3.71590864 |
| 33 | phospholipid efflux (GO:0033700) | 3.71473982 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.71304333 |
| 35 | positive regulation of cholesterol transport (GO:0032376) | 3.70567471 |
| 36 | positive regulation of sterol transport (GO:0032373) | 3.70567471 |
| 37 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.70386150 |
| 38 | adhesion of symbiont to host (GO:0044406) | 3.68703074 |
| 39 | keratan sulfate catabolic process (GO:0042340) | 3.60928147 |
| 40 | membrane lipid catabolic process (GO:0046466) | 3.54029139 |
| 41 | sphingolipid catabolic process (GO:0030149) | 3.53815350 |
| 42 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.52411799 |
| 43 | positive regulation of mast cell degranulation (GO:0043306) | 3.52411799 |
| 44 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.51322794 |
| 45 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.50772148 |
| 46 | skin morphogenesis (GO:0043589) | 3.50322137 |
| 47 | linoleic acid metabolic process (GO:0043651) | 3.47239440 |
| 48 | hyaluronan catabolic process (GO:0030214) | 3.43787551 |
| 49 | negative regulation of interleukin-17 production (GO:0032700) | 3.38711276 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 3.38180036 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 3.37747435 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.35615656 |
| 53 | desmosome organization (GO:0002934) | 3.33635221 |
| 54 | peptide cross-linking (GO:0018149) | 3.26928057 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.26382471 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.25804208 |
| 57 | receptor catabolic process (GO:0032801) | 3.23819864 |
| 58 | barbed-end actin filament capping (GO:0051016) | 3.22306486 |
| 59 | detection of biotic stimulus (GO:0009595) | 3.20282709 |
| 60 | epidermal cell differentiation (GO:0009913) | 3.18159264 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.17591633 |
| 62 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.17553376 |
| 63 | cellular response to arsenic-containing substance (GO:0071243) | 3.15131736 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14819909 |
| 65 | negative regulation of granulocyte differentiation (GO:0030853) | 3.14177940 |
| 66 | response to peptidoglycan (GO:0032494) | 3.11369972 |
| 67 | positive regulation of interferon-alpha production (GO:0032727) | 3.10167599 |
| 68 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.07051389 |
| 69 | regulation of macrophage chemotaxis (GO:0010758) | 3.03586445 |
| 70 | regulation of cholesterol efflux (GO:0010874) | 3.03109077 |
| 71 | negative regulation of macrophage differentiation (GO:0045650) | 3.02457878 |
| 72 | pinocytosis (GO:0006907) | 3.01429848 |
| 73 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.99399045 |
| 74 | surfactant homeostasis (GO:0043129) | 2.99275833 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.99099743 |
| 76 | negative regulation of interleukin-12 production (GO:0032695) | 2.98838429 |
| 77 | protein localization to endosome (GO:0036010) | 2.98374357 |
| 78 | vagina development (GO:0060068) | 2.95064155 |
| 79 | phagosome maturation (GO:0090382) | 2.94170727 |
| 80 | germ cell migration (GO:0008354) | 2.94093400 |
| 81 | response to host immune response (GO:0052572) | 2.93970830 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.93970830 |
| 83 | regulation of monocyte chemotaxis (GO:0090025) | 2.91468020 |
| 84 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89683907 |
| 85 | response to host (GO:0075136) | 2.89683907 |
| 86 | response to host defenses (GO:0052200) | 2.89683907 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.88948284 |
| 88 | lysosome organization (GO:0007040) | 2.88558908 |
| 89 | lytic vacuole organization (GO:0080171) | 2.88558908 |
| 90 | macrophage activation (GO:0042116) | 2.86936757 |
| 91 | regulation of interferon-alpha production (GO:0032647) | 2.86829926 |
| 92 | basement membrane organization (GO:0071711) | 2.85423179 |
| 93 | regulation of cholesterol storage (GO:0010885) | 2.84551570 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.84301557 |
| 95 | adhesion of symbiont to host cell (GO:0044650) | 2.83039140 |
| 96 | virion attachment to host cell (GO:0019062) | 2.83039140 |
| 97 | amyloid precursor protein catabolic process (GO:0042987) | 2.81637073 |
| 98 | detection of molecule of bacterial origin (GO:0032490) | 2.76368222 |
| 99 | response to acidic pH (GO:0010447) | 2.76171984 |
| 100 | protein carboxylation (GO:0018214) | 2.76033016 |
| 101 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.76033016 |
| 102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.74916184 |
| 103 | vitamin D metabolic process (GO:0042359) | 2.74598746 |
| 104 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.72377318 |
| 105 | regulation of hypersensitivity (GO:0002883) | 2.72307773 |
| 106 | alpha-linolenic acid metabolic process (GO:0036109) | 2.69695388 |
| 107 | cellular response to cadmium ion (GO:0071276) | 2.69470757 |
| 108 | positive regulation of chemokine secretion (GO:0090197) | 2.69265249 |
| 109 | positive regulation of regulated secretory pathway (GO:1903307) | 2.68477231 |
| 110 | negative regulation of interferon-gamma production (GO:0032689) | 2.68019404 |
| 111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.66816005 |
| 112 | regulation of cellular amide metabolic process (GO:0034248) | 2.66343941 |
| 113 | regulation of regulated secretory pathway (GO:1903305) | 2.65046971 |
| 114 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64458030 |
| 115 | response to interferon-alpha (GO:0035455) | 2.63966708 |
| 116 | regulation of mast cell activation (GO:0033003) | 2.63572010 |
| 117 | epidermis development (GO:0008544) | 2.59359436 |
| 118 | estrogen metabolic process (GO:0008210) | 2.58089372 |
| 119 | transferrin transport (GO:0033572) | 2.57862013 |
| 120 | positive regulation of p38MAPK cascade (GO:1900745) | 2.55821677 |
| 121 | fibroblast migration (GO:0010761) | 2.55810457 |
| 122 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.53746967 |
| 123 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.53043967 |
| 124 | positive regulation of male gonad development (GO:2000020) | 2.52778095 |
| 125 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.51155929 |
| 126 | cyclooxygenase pathway (GO:0019371) | 2.49840440 |
| 127 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.49328039 |
| 128 | endothelium development (GO:0003158) | 2.49321820 |
| 129 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.48466860 |
| 130 | chemical homeostasis within a tissue (GO:0048875) | 2.48266544 |
| 131 | low-density lipoprotein particle clearance (GO:0034383) | 2.47059634 |
| 132 | ferric iron transport (GO:0015682) | 2.46343740 |
| 133 | trivalent inorganic cation transport (GO:0072512) | 2.46343740 |
| 134 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.45646433 |
| 135 | defense response to Gram-negative bacterium (GO:0050829) | 2.43978952 |
| 136 | regulation of chemokine secretion (GO:0090196) | 2.43907685 |
| 137 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.43895698 |
| 138 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.39734413 |
| 139 | positive regulation of lipid storage (GO:0010884) | 2.38960061 |
| 140 | natural killer cell differentiation (GO:0001779) | 2.37527394 |
| 141 | response to fluid shear stress (GO:0034405) | 2.37367752 |
| 142 | cellular response to interferon-alpha (GO:0035457) | 2.36983810 |
| 143 | sex determination (GO:0007530) | 2.35168258 |
| 144 | I-kappaB phosphorylation (GO:0007252) | 2.33807309 |
| 145 | peptide catabolic process (GO:0043171) | 2.32577118 |
| 146 | progesterone metabolic process (GO:0042448) | 2.30287644 |
| 147 | reverse cholesterol transport (GO:0043691) | 2.28779694 |
| 148 | response to laminar fluid shear stress (GO:0034616) | 2.27451173 |
| 149 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.27392095 |
| 150 | cortical actin cytoskeleton organization (GO:0030866) | 2.26198976 |
| 151 | regulation of male gonad development (GO:2000018) | 2.25908580 |
| 152 | lipoprotein transport (GO:0042953) | 2.24924707 |
| 153 | epoxygenase P450 pathway (GO:0019373) | 2.22562394 |
| 154 | regulation of gonadotropin secretion (GO:0032276) | 2.21600367 |
| 155 | tolerance induction (GO:0002507) | 2.21515249 |
| 156 | androgen metabolic process (GO:0008209) | 2.21405861 |
| 157 | phagocytosis (GO:0006909) | 2.21255623 |
| 158 | cellular response to growth hormone stimulus (GO:0071378) | 2.20125263 |
| 159 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.20013977 |
| 160 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.19040590 |
| 161 | cellular response to antibiotic (GO:0071236) | 2.18625903 |
| 162 | phospholipid homeostasis (GO:0055091) | 2.17546089 |
| 163 | stress fiber assembly (GO:0043149) | 2.17294451 |
| 164 | substrate-dependent cell migration (GO:0006929) | 2.17209170 |
| 165 | negative regulation of interleukin-6 production (GO:0032715) | 2.16918534 |
| 166 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.16855727 |
| 167 | glycosphingolipid catabolic process (GO:0046479) | 2.16116457 |
| 168 | oligosaccharide catabolic process (GO:0009313) | 2.16099722 |
| 169 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.15873774 |
| 170 | response to thyroid hormone (GO:0097066) | 2.15841321 |
| 171 | decidualization (GO:0046697) | 2.15537803 |
| 172 | positive regulation of phagocytosis (GO:0050766) | 2.14188587 |
| 173 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.12901065 |
| 174 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.12815862 |
| 175 | keratinization (GO:0031424) | 11.2434572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.37364137 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.00145569 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.97011645 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.89789078 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.83949906 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60837030 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.60726460 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57010416 |
| 9 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.50474664 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47181029 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.46878111 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.33884478 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.24788912 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.19290352 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12964872 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12816972 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.09559123 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07320861 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07049995 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06733389 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05987443 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98946040 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82841040 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81368417 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.80173628 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61317118 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61208642 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60899286 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51301069 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50738630 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50628448 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47032486 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46921527 |
| 34 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46673149 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46577699 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46375372 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45347763 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44803404 |
| 39 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.43385890 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41216305 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40034546 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36568320 |
| 43 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33217441 |
| 44 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31962717 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31843220 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30857143 |
| 47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28776514 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28552399 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28346867 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27898466 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.27706268 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.27117762 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26265118 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26136047 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.25512656 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25410238 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24411102 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23741118 |
| 59 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23732889 |
| 60 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23732889 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23244039 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21828289 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21027032 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20253481 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19126157 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18888741 |
| 67 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18829325 |
| 68 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18829325 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17586323 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17412877 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17252193 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16936532 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15600781 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15430696 |
| 75 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.14521885 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12968535 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12260678 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12192572 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10843655 |
| 80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10015946 |
| 81 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09883594 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09525768 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08201371 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07409138 |
| 85 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07349979 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06451849 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05589805 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05387987 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04569836 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04483805 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03862812 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03527500 |
| 93 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02332561 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02310507 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01654818 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01240654 |
| 97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00905561 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00890985 |
| 99 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00197641 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98286949 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96059466 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95879305 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94819978 |
| 104 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94369591 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94274365 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93986828 |
| 107 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93932453 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93777179 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93475072 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92320751 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92136796 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92100916 |
| 113 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92082777 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91985022 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91646265 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91624764 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90883162 |
| 118 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90779636 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90738897 |
| 120 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90325426 |
| 121 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90252540 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90151353 |
| 123 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89984192 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89954607 |
| 125 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89723868 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88993146 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87973578 |
| 128 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87543590 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.87302303 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85962427 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85058877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 6.11485057 |
| 2 | MP0005058_abnormal_lysosome_morphology | 5.06029681 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.19674108 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.97771068 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.32303838 |
| 6 | MP0009840_abnormal_foam_cell | 3.23796678 |
| 7 | MP0003303_peritoneal_inflammation | 3.18598556 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.09343461 |
| 9 | MP0005501_abnormal_skin_physiology | 3.06499088 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.44170297 |
| 11 | MP0003453_abnormal_keratinocyte_physiol | 2.41025995 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.34982645 |
| 13 | MP0004947_skin_inflammation | 2.25786498 |
| 14 | MP0006082_CNS_inflammation | 2.23643282 |
| 15 | MP0003045_fibrosis | 2.16597532 |
| 16 | MP0003252_abnormal_bile_duct | 2.05223303 |
| 17 | MP0003195_calcinosis | 2.02537345 |
| 18 | MP0001216_abnormal_epidermal_layer | 1.95730520 |
| 19 | MP0000579_abnormal_nail_morphology | 1.95516419 |
| 20 | MP0005360_urolithiasis | 1.93796388 |
| 21 | MP0001958_emphysema | 1.81630447 |
| 22 | MP0003941_abnormal_skin_development | 1.72008988 |
| 23 | MP0000343_altered_response_to | 1.71957181 |
| 24 | MP0004381_abnormal_hair_follicle | 1.66242568 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.65098205 |
| 26 | MP0010678_abnormal_skin_adnexa | 1.62988580 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.62931912 |
| 28 | MP0004130_abnormal_muscle_cell | 1.61036509 |
| 29 | MP0003329_amyloid_beta_deposits | 1.60189852 |
| 30 | MP0009384_cardiac_valve_regurgitation | 1.58605765 |
| 31 | MP0003279_aneurysm | 1.57967220 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.54858426 |
| 33 | MP0002419_abnormal_innate_immunity | 1.51065616 |
| 34 | MP0008004_abnormal_stomach_pH | 1.50193764 |
| 35 | MP0003011_delayed_dark_adaptation | 1.49945335 |
| 36 | MP0003690_abnormal_glial_cell | 1.47777878 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.46577841 |
| 38 | MP0004782_abnormal_surfactant_physiolog | 1.46445248 |
| 39 | MP0000685_abnormal_immune_system | 1.45511244 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.44544697 |
| 41 | MP0005666_abnormal_adipose_tissue | 1.44051819 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.42253282 |
| 43 | MP0000377_abnormal_hair_follicle | 1.41725574 |
| 44 | MP0002098_abnormal_vibrissa_morphology | 1.41026366 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.39928459 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.39602550 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.39208033 |
| 48 | MP0010771_integument_phenotype | 1.38590971 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.38558087 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.36791266 |
| 51 | MP0005670_abnormal_white_adipose | 1.35918632 |
| 52 | MP0002060_abnormal_skin_morphology | 1.35616024 |
| 53 | MP0003724_increased_susceptibility_to | 1.32881144 |
| 54 | MP0005365_abnormal_bile_salt | 1.31715406 |
| 55 | MP0002168_other_aberrant_phenotype | 1.30692885 |
| 56 | MP0008260_abnormal_autophagy | 1.30173636 |
| 57 | MP0002090_abnormal_vision | 1.28920469 |
| 58 | MP0003436_decreased_susceptibility_to | 1.27939751 |
| 59 | MP0009278_abnormal_bone_marrow | 1.26530523 |
| 60 | MP0005387_immune_system_phenotype | 1.25076594 |
| 61 | MP0001790_abnormal_immune_system | 1.25076594 |
| 62 | MP0004883_abnormal_blood_vessel | 1.22673221 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.21972571 |
| 64 | MP0004510_myositis | 1.20289118 |
| 65 | MP0005671_abnormal_response_to | 1.19943124 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.17160336 |
| 67 | MP0006054_spinal_hemorrhage | 1.17135786 |
| 68 | MP0005409_darkened_coat_color | 1.16239800 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.15448670 |
| 70 | MP0003828_pulmonary_edema | 1.15445006 |
| 71 | MP0000371_diluted_coat_color | 1.15303477 |
| 72 | MP0005275_abnormal_skin_tensile | 1.14393583 |
| 73 | MP0003075_altered_response_to | 1.13807533 |
| 74 | MP0004084_abnormal_cardiac_muscle | 1.13387132 |
| 75 | MP0000604_amyloidosis | 1.12601118 |
| 76 | MP0004272_abnormal_basement_membrane | 1.12389155 |
| 77 | MP0008469_abnormal_protein_level | 1.11997624 |
| 78 | MP0005375_adipose_tissue_phenotype | 1.11207699 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 1.10644413 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10465103 |
| 81 | MP0002909_abnormal_adrenal_gland | 1.10207079 |
| 82 | MP0000920_abnormal_myelination | 1.09909242 |
| 83 | MP0000639_abnormal_adrenal_gland | 1.08287694 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 1.07099145 |
| 85 | MP0004885_abnormal_endolymph | 1.05987344 |
| 86 | MP0000767_abnormal_smooth_muscle | 1.05446854 |
| 87 | MP0000383_abnormal_hair_follicle | 1.03913709 |
| 88 | MP0000249_abnormal_blood_vessel | 1.03716702 |
| 89 | MP0001756_abnormal_urination | 1.02588491 |
| 90 | MP0005023_abnormal_wound_healing | 0.99609432 |
| 91 | MP0000647_abnormal_sebaceous_gland | 0.96224989 |
| 92 | MP0000609_abnormal_liver_physiology | 0.96167438 |
| 93 | MP0001191_abnormal_skin_condition | 0.95808701 |
| 94 | MP0009931_abnormal_skin_appearance | 0.95739934 |
| 95 | MP0003866_abnormal_defecation | 0.94394158 |
| 96 | MP0000751_myopathy | 0.93467659 |
| 97 | MP0002971_abnormal_brown_adipose | 0.92411742 |
| 98 | MP0005257_abnormal_intraocular_pressure | 0.92210067 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.92139967 |
| 100 | MP0001853_heart_inflammation | 0.91944505 |
| 101 | MP0003634_abnormal_glial_cell | 0.91882320 |
| 102 | MP0005165_increased_susceptibility_to | 0.91394338 |
| 103 | MP0005310_abnormal_salivary_gland | 0.91296430 |
| 104 | MP0001851_eye_inflammation | 0.91157778 |
| 105 | MP0009785_altered_susceptibility_to | 0.90568918 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.90357952 |
| 107 | MP0000367_abnormal_coat/_hair | 0.89312885 |
| 108 | MP0002254_reproductive_system_inflammat | 0.89072388 |
| 109 | MP0002723_abnormal_immune_serum | 0.84944404 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.84901214 |
| 111 | MP0002452_abnormal_antigen_presenting | 0.84632951 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.83074421 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.82940679 |
| 114 | MP0002837_dystrophic_cardiac_calcinosis | 0.82462879 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.82421677 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.81004624 |
| 117 | MP0003795_abnormal_bone_structure | 0.80675806 |
| 118 | MP0002118_abnormal_lipid_homeostasis | 0.80513551 |
| 119 | MP0003091_abnormal_cell_migration | 0.79962073 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.78631883 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.78454188 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.77774159 |
| 123 | MP0005025_abnormal_response_to | 0.77570789 |
| 124 | MP0005390_skeleton_phenotype | 0.77390109 |
| 125 | MP0005166_decreased_susceptibility_to | 0.77074889 |
| 126 | MP0001879_abnormal_lymphatic_vessel | 0.76657345 |
| 127 | MP0003879_abnormal_hair_cell | 0.76064360 |
| 128 | MP0005248_abnormal_Harderian_gland | 0.75420700 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.75321003 |
| 130 | MP0005164_abnormal_response_to | 0.74997820 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.74361345 |
| 132 | MP0000598_abnormal_liver_morphology | 0.74041071 |
| 133 | MP0002928_abnormal_bile_duct | 0.73941078 |
| 134 | MP0000569_abnormal_digit_pigmentation | 0.73919789 |
| 135 | MP0000538_abnormal_urinary_bladder | 0.73918983 |
| 136 | MP0002135_abnormal_kidney_morphology | 0.72863020 |
| 137 | MP0005647_abnormal_sex_gland | 0.72834908 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72672971 |
| 139 | MP0005451_abnormal_body_composition | 0.72316340 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.70307463 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.70178943 |
| 142 | MP0003878_abnormal_ear_physiology | 0.70044930 |
| 143 | MP0005377_hearing/vestibular/ear_phenot | 0.70044930 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.69723017 |
| 145 | MP0000858_altered_metastatic_potential | 0.69132987 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.68735037 |
| 147 | MP0001819_abnormal_immune_cell | 0.68608896 |
| 148 | MP0003448_altered_tumor_morphology | 0.68480898 |
| 149 | MP0002420_abnormal_adaptive_immunity | 0.67492515 |
| 150 | MP0002405_respiratory_system_inflammati | 0.66306039 |
| 151 | MP0001800_abnormal_humoral_immune | 0.62797095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of nail color (HP:0100643) | 6.59237960 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.74804727 |
| 3 | Increased IgE level (HP:0003212) | 5.40793356 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.22001882 |
| 5 | Dysostosis multiplex (HP:0000943) | 5.21581068 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.66067538 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.66067538 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.66067538 |
| 9 | Glomerulonephritis (HP:0000099) | 4.60469176 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.50966142 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.44045825 |
| 12 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.41787521 |
| 13 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.35304470 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.18771375 |
| 15 | Mucopolysacchariduria (HP:0008155) | 4.18771375 |
| 16 | Palmoplantar hyperkeratosis (HP:0000972) | 4.13069503 |
| 17 | Retinal atrophy (HP:0001105) | 4.05398289 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.01030984 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.01030984 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.01030984 |
| 21 | Complement deficiency (HP:0004431) | 3.96773779 |
| 22 | Palmar hyperkeratosis (HP:0010765) | 3.85292475 |
| 23 | Neurofibrillary tangles (HP:0002185) | 3.60997303 |
| 24 | Parakeratosis (HP:0001036) | 3.59387342 |
| 25 | Cerebral aneurysm (HP:0004944) | 3.52658516 |
| 26 | Erythema (HP:0010783) | 3.38354050 |
| 27 | Axonal loss (HP:0003447) | 3.36794962 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.35514411 |
| 29 | Thick nail (HP:0001805) | 3.32218585 |
| 30 | Plantar hyperkeratosis (HP:0007556) | 3.26163105 |
| 31 | Abnormality of the axillary hair (HP:0100134) | 3.18841821 |
| 32 | Abnormality of secondary sexual hair (HP:0009888) | 3.18841821 |
| 33 | Erythroderma (HP:0001019) | 3.13621877 |
| 34 | Colitis (HP:0002583) | 3.07758102 |
| 35 | Arterial tortuosity (HP:0005116) | 3.06697596 |
| 36 | Onycholysis (HP:0001806) | 3.04120387 |
| 37 | Abnormality of complement system (HP:0005339) | 3.03686678 |
| 38 | Premature rupture of membranes (HP:0001788) | 2.98659860 |
| 39 | Loss of speech (HP:0002371) | 2.96183631 |
| 40 | Nephritis (HP:0000123) | 2.96160454 |
| 41 | Gonadotropin excess (HP:0000837) | 2.94062974 |
| 42 | Corneal erosion (HP:0200020) | 2.88685695 |
| 43 | Aortic aneurysm (HP:0004942) | 2.87715221 |
| 44 | Alopecia of scalp (HP:0002293) | 2.80106462 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.79638086 |
| 46 | Spondylolisthesis (HP:0003302) | 2.78916692 |
| 47 | Striae distensae (HP:0001065) | 2.77493465 |
| 48 | Pustule (HP:0200039) | 2.77449245 |
| 49 | Vascular tortuosity (HP:0004948) | 2.75777446 |
| 50 | Aortic dissection (HP:0002647) | 2.74911398 |
| 51 | Disproportionate tall stature (HP:0001519) | 2.59952374 |
| 52 | Hematochezia (HP:0002573) | 2.58263921 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.56967950 |
| 54 | Hypotrichosis (HP:0001006) | 2.54664446 |
| 55 | Eczematoid dermatitis (HP:0000976) | 2.54256271 |
| 56 | Disinhibition (HP:0000734) | 2.53580481 |
| 57 | Nuclear cataract (HP:0100018) | 2.51009793 |
| 58 | Thoracic kyphosis (HP:0002942) | 2.46874719 |
| 59 | Ectropion (HP:0000656) | 2.46141292 |
| 60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43692721 |
| 61 | Oral leukoplakia (HP:0002745) | 2.38063143 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.34690580 |
| 63 | Apathy (HP:0000741) | 2.34506441 |
| 64 | Gangrene (HP:0100758) | 2.34310648 |
| 65 | Diminished motivation (HP:0000745) | 2.32623679 |
| 66 | Enlarged penis (HP:0000040) | 2.32337557 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.31914692 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 2.31607678 |
| 69 | Purpura (HP:0000979) | 2.28964609 |
| 70 | Mutism (HP:0002300) | 2.25433098 |
| 71 | Mitral valve prolapse (HP:0001634) | 2.24503400 |
| 72 | Recurrent skin infections (HP:0001581) | 2.24225568 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.24047062 |
| 74 | Hypohidrosis (HP:0000966) | 2.22068580 |
| 75 | Inappropriate behavior (HP:0000719) | 2.20495255 |
| 76 | Cardiomegaly (HP:0001640) | 2.20038964 |
| 77 | Myocardial infarction (HP:0001658) | 2.17584271 |
| 78 | Ovoid vertebral bodies (HP:0003300) | 2.13478475 |
| 79 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12532354 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.12407417 |
| 81 | Agnosia (HP:0010524) | 2.12332185 |
| 82 | Lymphangioma (HP:0100764) | 2.12331985 |
| 83 | Urticaria (HP:0001025) | 2.10511182 |
| 84 | Increased connective tissue (HP:0009025) | 2.10201113 |
| 85 | Hyperpituitarism (HP:0010514) | 2.06944274 |
| 86 | Dementia (HP:0000726) | 2.06245797 |
| 87 | Abnormality of the lumbar spine (HP:0100712) | 2.06102991 |
| 88 | Amyloidosis (HP:0011034) | 2.04854317 |
| 89 | Ankle contracture (HP:0006466) | 2.04790137 |
| 90 | Progressive visual loss (HP:0000529) | 2.04006952 |
| 91 | Abnormality of macrophages (HP:0004311) | 2.03740890 |
| 92 | Xanthomatosis (HP:0000991) | 2.02020834 |
| 93 | Palmoplantar keratoderma (HP:0000982) | 2.01922679 |
| 94 | Personality changes (HP:0000751) | 2.00473751 |
| 95 | Cervical subluxation (HP:0003308) | 1.99680520 |
| 96 | Polycythemia (HP:0001901) | 1.97790998 |
| 97 | J-shaped sella turcica (HP:0002680) | 1.96377702 |
| 98 | Vertebral compression fractures (HP:0002953) | 1.95985624 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93021783 |
| 100 | Subcapsular cataract (HP:0000523) | 1.92578521 |
| 101 | Increased CSF protein (HP:0002922) | 1.92502641 |
| 102 | Distal lower limb muscle weakness (HP:0009053) | 1.92372064 |
| 103 | Pathologic fracture (HP:0002756) | 1.91865813 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 1.91671483 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 1.91246532 |
| 106 | Spontaneous hematomas (HP:0007420) | 1.90617369 |
| 107 | Testicular neoplasm (HP:0010788) | 1.90486742 |
| 108 | Broad metatarsal (HP:0001783) | 1.89064449 |
| 109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88167205 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 1.86156825 |
| 111 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85695573 |
| 112 | Conjunctival hamartoma (HP:0100780) | 1.84973651 |
| 113 | Prolonged neonatal jaundice (HP:0006579) | 1.83801685 |
| 114 | Nail dystrophy (HP:0008404) | 1.83254708 |
| 115 | Shallow orbits (HP:0000586) | 1.83024175 |
| 116 | Nausea (HP:0002018) | 1.82913163 |
| 117 | Basal ganglia calcification (HP:0002135) | 1.82565749 |
| 118 | Abnormality of proline metabolism (HP:0010907) | 1.81871659 |
| 119 | Hydroxyprolinuria (HP:0003080) | 1.81871659 |
| 120 | Abnormal platelet function (HP:0011869) | 1.81868848 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.81868848 |
| 122 | Hand muscle atrophy (HP:0009130) | 1.80530000 |
| 123 | Nonimmune hydrops fetalis (HP:0001790) | 1.79087000 |
| 124 | Bone cyst (HP:0012062) | 1.78562618 |
| 125 | Facial diplegia (HP:0001349) | 1.78429311 |
| 126 | Mesangial abnormality (HP:0001966) | 1.78167199 |
| 127 | Aneurysm (HP:0002617) | 1.78076976 |
| 128 | Pruritus (HP:0000989) | 1.77597880 |
| 129 | Supranuclear gaze palsy (HP:0000605) | 1.76606131 |
| 130 | Soft skin (HP:0000977) | 1.76465141 |
| 131 | Camptodactyly of toe (HP:0001836) | 1.76241772 |
| 132 | Paralysis (HP:0003470) | 1.76098166 |
| 133 | Joint stiffness (HP:0001387) | 1.74866842 |
| 134 | Upper motor neuron abnormality (HP:0002127) | 1.73873219 |
| 135 | Renal salt wasting (HP:0000127) | 1.73605093 |
| 136 | Right ventricular cardiomyopathy (HP:0011663) | 1.73039671 |
| 137 | Atrophic scars (HP:0001075) | 1.72858022 |
| 138 | Thyroid-stimulating hormone excess (HP:0002925) | 1.72662021 |
| 139 | Peripheral demyelination (HP:0011096) | 1.72035224 |
| 140 | Gonadal dysgenesis (HP:0000133) | 1.71831989 |
| 141 | Gingivitis (HP:0000230) | 1.71315065 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 1.69077992 |
| 143 | Global brain atrophy (HP:0002283) | 1.69049257 |
| 144 | Conjunctival telangiectasia (HP:0000524) | 1.68031201 |
| 145 | Abnormality of the thoracic spine (HP:0100711) | 1.67275846 |
| 146 | Bone pain (HP:0002653) | 1.66088282 |
| 147 | Joint hemorrhage (HP:0005261) | 1.66078242 |
| 148 | Late onset (HP:0003584) | 1.65902710 |
| 149 | Petechiae (HP:0000967) | 1.65076807 |
| 150 | Fragile skin (HP:0001030) | 1.64613217 |
| 151 | Thin bony cortex (HP:0002753) | 1.64314632 |
| 152 | Natal tooth (HP:0000695) | 1.63204622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.11668958 |
| 2 | TRIB3 | 4.35009417 |
| 3 | MAP2K3 | 3.26362205 |
| 4 | PKN2 | 3.00116215 |
| 5 | ERN1 | 2.85893842 |
| 6 | EEF2K | 2.44559391 |
| 7 | PAK4 | 2.34088636 |
| 8 | TAOK2 | 2.09476106 |
| 9 | MAP3K6 | 2.07644758 |
| 10 | TBK1 | 2.06292942 |
| 11 | TESK1 | 2.01656008 |
| 12 | ZAP70 | 1.93059375 |
| 13 | TTN | 1.88443621 |
| 14 | EPHA2 | 1.83054836 |
| 15 | PTK6 | 1.81469489 |
| 16 | TAOK1 | 1.75044593 |
| 17 | MAPK15 | 1.68491085 |
| 18 | CSF1R | 1.61812217 |
| 19 | CAMK1D | 1.52448670 |
| 20 | MAP3K9 | 1.52401912 |
| 21 | TYK2 | 1.51063998 |
| 22 | ABL2 | 1.47459353 |
| 23 | TGFBR1 | 1.46230233 |
| 24 | RIPK1 | 1.46044339 |
| 25 | MAPKAPK3 | 1.45804918 |
| 26 | DMPK | 1.44897530 |
| 27 | PRPF4B | 1.44565693 |
| 28 | KDR | 1.42532623 |
| 29 | MAP3K13 | 1.40252129 |
| 30 | DDR2 | 1.39030103 |
| 31 | BLK | 1.36744178 |
| 32 | MAP3K14 | 1.30291837 |
| 33 | KIT | 1.30085288 |
| 34 | FGR | 1.29642017 |
| 35 | EPHB1 | 1.28003666 |
| 36 | TNK2 | 1.24655932 |
| 37 | CDC42BPA | 1.24406024 |
| 38 | GRK7 | 1.24106489 |
| 39 | IRAK2 | 1.24055965 |
| 40 | RET | 1.22031877 |
| 41 | SCYL2 | 1.21659199 |
| 42 | WNK3 | 1.21350935 |
| 43 | RIPK4 | 1.21288554 |
| 44 | MATK | 1.15367974 |
| 45 | RPS6KA4 | 1.15205644 |
| 46 | MAPK12 | 1.13221907 |
| 47 | WNK4 | 1.12861051 |
| 48 | PIK3CG | 1.11920821 |
| 49 | CAMK1G | 1.07384227 |
| 50 | MAP2K4 | 1.04383601 |
| 51 | SGK3 | 1.04147071 |
| 52 | LMTK2 | 1.01761015 |
| 53 | PDGFRA | 1.01710136 |
| 54 | JAK1 | 0.99352410 |
| 55 | MAP2K6 | 0.98529329 |
| 56 | MYLK | 0.97262788 |
| 57 | MARK2 | 0.96230084 |
| 58 | PTK2B | 0.95777938 |
| 59 | NME2 | 0.95426224 |
| 60 | JAK2 | 0.95345933 |
| 61 | TRPM7 | 0.94714204 |
| 62 | PRKD2 | 0.93539830 |
| 63 | NEK9 | 0.92723331 |
| 64 | FER | 0.92537153 |
| 65 | BCKDK | 0.90258316 |
| 66 | STK24 | 0.89031521 |
| 67 | CSK | 0.86534878 |
| 68 | KSR2 | 0.86424801 |
| 69 | MAP2K1 | 0.85584248 |
| 70 | SGK2 | 0.85342859 |
| 71 | AKT3 | 0.79154135 |
| 72 | CDK6 | 0.78974530 |
| 73 | IRAK3 | 0.77788267 |
| 74 | MAP3K1 | 0.75774285 |
| 75 | PIM2 | 0.75738356 |
| 76 | STK10 | 0.75520831 |
| 77 | IKBKB | 0.75325747 |
| 78 | CAMKK2 | 0.75084481 |
| 79 | CDK3 | 0.74896217 |
| 80 | MAP3K10 | 0.74677864 |
| 81 | LIMK1 | 0.73288744 |
| 82 | CAMKK1 | 0.72387140 |
| 83 | ARAF | 0.71905152 |
| 84 | TIE1 | 0.71840288 |
| 85 | SIK1 | 0.71427159 |
| 86 | FES | 0.69545990 |
| 87 | SGK494 | 0.69264617 |
| 88 | SGK223 | 0.69264617 |
| 89 | LRRK2 | 0.68000895 |
| 90 | TESK2 | 0.67756254 |
| 91 | TNIK | 0.67609191 |
| 92 | FGFR4 | 0.67361103 |
| 93 | MAP3K2 | 0.66636685 |
| 94 | EPHA3 | 0.66608452 |
| 95 | PRKCH | 0.66010646 |
| 96 | SYK | 0.64876150 |
| 97 | MAP4K1 | 0.63650890 |
| 98 | JAK3 | 0.63338802 |
| 99 | PAK2 | 0.59199889 |
| 100 | DAPK2 | 0.58853239 |
| 101 | MAP2K2 | 0.58845463 |
| 102 | IGF1R | 0.58687202 |
| 103 | EPHB2 | 0.58681270 |
| 104 | IRAK4 | 0.58556710 |
| 105 | PRKAA2 | 0.58306969 |
| 106 | MARK3 | 0.58058181 |
| 107 | NLK | 0.56718253 |
| 108 | RPS6KA2 | 0.54993101 |
| 109 | MAP3K5 | 0.54940561 |
| 110 | HIPK2 | 0.53844592 |
| 111 | DYRK1B | 0.51275262 |
| 112 | MAP3K3 | 0.51163022 |
| 113 | HCK | 0.50629375 |
| 114 | ILK | 0.50625517 |
| 115 | LYN | 0.49662902 |
| 116 | MAPK11 | 0.49658947 |
| 117 | PTK2 | 0.49387038 |
| 118 | PDPK1 | 0.49023043 |
| 119 | IKBKE | 0.48397479 |
| 120 | PDK2 | 0.48240948 |
| 121 | BTK | 0.48161332 |
| 122 | PDGFRB | 0.47130971 |
| 123 | GSK3A | 0.46881087 |
| 124 | EGFR | 0.46240995 |
| 125 | CAMK4 | 0.45637175 |
| 126 | ABL1 | 0.44843922 |
| 127 | PDK1 | 0.44831350 |
| 128 | MTOR | 0.44711144 |
| 129 | MAPK7 | 0.43765892 |
| 130 | ITK | 0.42009651 |
| 131 | CHUK | 0.41429327 |
| 132 | ACVR1B | 0.40970569 |
| 133 | RPS6KL1 | 0.40143270 |
| 134 | RPS6KC1 | 0.40143270 |
| 135 | IRAK1 | 0.40074012 |
| 136 | ICK | 0.40063199 |
| 137 | TAOK3 | 0.40004152 |
| 138 | MOS | 0.39924287 |
| 139 | BMX | 0.39323986 |
| 140 | MAP3K11 | 0.38175084 |
| 141 | PRKD1 | 0.36056371 |
| 142 | PAK6 | 0.35809472 |
| 143 | MAPKAPK5 | 0.35563512 |
| 144 | FLT3 | 0.34306950 |
| 145 | MAPKAPK2 | 0.33077404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.43215520 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.42345065 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.09708704 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02855247 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.26120917 |
| 6 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.97767469 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.92825858 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89751108 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87445822 |
| 10 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.80791865 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68641778 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63139169 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62388942 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61571965 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.52701198 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45087050 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.40302372 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37570458 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32228976 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28908821 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.23882567 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20849542 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19207254 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16898347 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13449810 |
| 26 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13184122 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13180266 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12268967 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09855812 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09346341 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08522562 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06676054 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05541595 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.05052291 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01558896 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01195995 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00945356 |
| 38 | Lysine degradation_Homo sapiens_hsa00310 | 0.98699113 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97154762 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95483119 |
| 41 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94638013 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 0.94015409 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.93007293 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91461621 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.90413675 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89728897 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.89462872 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89115122 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88987388 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.88393275 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87473357 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.86401474 |
| 53 | Asthma_Homo sapiens_hsa05310 | 0.86234466 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.85760902 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85140540 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84195843 |
| 57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83494583 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.81973589 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.81512621 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81360786 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80804643 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78489746 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77605709 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77585784 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77191424 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76054428 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75443083 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.75084283 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74493048 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73813900 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72685894 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.72233346 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71584080 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70968059 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70732723 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.70571406 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70206727 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69329621 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69316702 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69121997 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.68943581 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68462632 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64919514 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64287751 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63170017 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63124035 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62631149 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62542148 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62535974 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62174503 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61735569 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.61634289 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61107361 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60947675 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60684972 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60509117 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60491466 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60351567 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.59956378 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59735914 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.59578617 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59547615 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58661517 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.58077058 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.57209454 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56742861 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56084794 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55827161 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55477894 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.54224538 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52563532 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52526784 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.52183218 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50170400 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49729330 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49418622 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48288726 |
| 118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48167051 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46944973 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45699662 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45428707 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.44023764 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.44005259 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43850257 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43236769 |
| 126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43115181 |
| 127 | Long-term depression_Homo sapiens_hsa04730 | 0.43044470 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43026445 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42844282 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41934897 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40866026 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40482536 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39844437 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39193866 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38863696 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38489890 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37515768 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37227362 |
| 139 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35935526 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35594681 |
| 141 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35468814 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35148625 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34669074 |
| 144 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34469562 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32203916 |
| 146 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30947116 |

